Parenteral Drugs (India)

quarterly
yearly
ParticularsMar '21Jun '21Sep '21Dec '21Mar '22
Revenue2.602.942.361.451.81
Expenses35.9644.0045.4245.6834.81
EBITDA3.42-2.63-3.26-3.22-5.85
EBIT-0.90-6.95-7.58-7.5519.21
Profit Before Tax-33.35-41.06-43.05-44.2219.21
Net Profit-24.84-32.04-33.61-34.5223.81
Financial Ratios
Operating Profit Margin133.07%-89.42%-138.72%-222.92%2,620%
Net Profit Margin-966.54%-1,094%-1,430%-2,397%-1,605%
Earning Per Share (Diluted)-8.33-10.74-11.28-11.587.99
Dividends Per Share0.000.000.000.000.00